心房颤动
医学
利钠肽
临床意义
入射(几何)
半乳糖凝集素-3
内科学
心脏病学
风险因素
生物标志物
重症监护医学
心力衰竭
生物
生物化学
光学
物理
作者
Khalil M. Charafeddine,Patrick Zakka,Bassel Bou Dargham,Farah Abdulhai,Katerina Zakka,Fouad A. Zouein,Marwan M. Refaat
出处
期刊:Journal of Cardiovascular Pharmacology
[Ovid Technologies (Wolters Kluwer)]
日期:2021-08-01
卷期号:78 (2): 184-191
被引量:6
标识
DOI:10.1097/fjc.0000000000001042
摘要
In risk-stratifying patients with atrial fibrillation (AF), physicians rely heavily on clinical parameters that provide risk scores and determine treatment strategies. There has been increasing research on potential biomarkers in the blood that could more accurately determine both risk of complications in AF and risk of incidence of AF. This review highlights the clinical significance of 5 novel biomarkers that have been shown to be linked to AF. These biomarkers are carbohydrate antigen 125, galectin-3, growth differentiation factor-15, a member of the interleukin 1 receptor family, IL1RL1 (ST2), and N-terminal pro B-type natriuretic peptide.
科研通智能强力驱动
Strongly Powered by AbleSci AI